Correction to: LncRNA PVT1 up-regulation is a poor prognosticator and serves as a therapeutic target in esophageal adenocarcinoma

An amendment to this paper has been published and can be accessed via the original article.

Bibliographic Details
Main Authors: Yan Xu, Yuan Li, Jiankang Jin, Guangchun Han, Chengcao Sun, Melissa Pool Pizzi, Longfei Huo, Ailing Scott, Ying Wang, Lang Ma, Jeffrey H. Lee, Manoop S. Bhutani, Brian Weston, Christopher Vellano, Liuqing Yang, Chunru Lin, Youngsoo Kim, A. Robert MacLeod, Linghua Wang, Zhenning Wang, Shumei Song, Jaffer A. Ajani
Format: Article
Language:English
Published: BMC 2021-03-01
Series:Molecular Cancer
Online Access:https://doi.org/10.1186/s12943-021-01351-5
id doaj-b54e9b5c5950425db19935873e7eeae8
record_format Article
spelling doaj-b54e9b5c5950425db19935873e7eeae82021-03-28T11:24:50ZengBMCMolecular Cancer1476-45982021-03-012011210.1186/s12943-021-01351-5Correction to: LncRNA PVT1 up-regulation is a poor prognosticator and serves as a therapeutic target in esophageal adenocarcinomaYan Xu0Yuan Li1Jiankang Jin2Guangchun Han3Chengcao Sun4Melissa Pool Pizzi5Longfei Huo6Ailing Scott7Ying Wang8Lang Ma9Jeffrey H. Lee10Manoop S. Bhutani11Brian Weston12Christopher Vellano13Liuqing Yang14Chunru Lin15Youngsoo Kim16A. Robert MacLeod17Linghua Wang18Zhenning Wang19Shumei Song20Jaffer A. Ajani21Departments of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer CenterDepartments of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer CenterDepartments of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer CenterDepartments of Genomic Medicine, The University of Texas MD Anderson Cancer CenterDepartments of Molecular & Cellular Oncology, The University of Texas MD Anderson Cancer CenterDepartments of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer CenterDepartments of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer CenterDepartments of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer CenterDepartments of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer CenterDepartments of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer CenterDepartments of Gastroenterology&Hepatology, The University of Texas MD Anderson Cancer CenterDepartments of Gastroenterology&Hepatology, The University of Texas MD Anderson Cancer CenterDepartments of Gastroenterology&Hepatology, The University of Texas MD Anderson Cancer CenterCenter for Co-Clinical Trial, The University of Texas MD Anderson Cancer CenterDepartments of Molecular & Cellular Oncology, The University of Texas MD Anderson Cancer CenterDepartments of Molecular & Cellular Oncology, The University of Texas MD Anderson Cancer CenterIonis Pharmaceuticals, Inc.Ionis Pharmaceuticals, Inc.Departments of Genomic Medicine, The University of Texas MD Anderson Cancer CenterDepartment of Surgical Oncology and General Surgery, First Hospital of China Medical UniversityDepartments of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer CenterDepartments of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer CenterAn amendment to this paper has been published and can be accessed via the original article.https://doi.org/10.1186/s12943-021-01351-5
collection DOAJ
language English
format Article
sources DOAJ
author Yan Xu
Yuan Li
Jiankang Jin
Guangchun Han
Chengcao Sun
Melissa Pool Pizzi
Longfei Huo
Ailing Scott
Ying Wang
Lang Ma
Jeffrey H. Lee
Manoop S. Bhutani
Brian Weston
Christopher Vellano
Liuqing Yang
Chunru Lin
Youngsoo Kim
A. Robert MacLeod
Linghua Wang
Zhenning Wang
Shumei Song
Jaffer A. Ajani
spellingShingle Yan Xu
Yuan Li
Jiankang Jin
Guangchun Han
Chengcao Sun
Melissa Pool Pizzi
Longfei Huo
Ailing Scott
Ying Wang
Lang Ma
Jeffrey H. Lee
Manoop S. Bhutani
Brian Weston
Christopher Vellano
Liuqing Yang
Chunru Lin
Youngsoo Kim
A. Robert MacLeod
Linghua Wang
Zhenning Wang
Shumei Song
Jaffer A. Ajani
Correction to: LncRNA PVT1 up-regulation is a poor prognosticator and serves as a therapeutic target in esophageal adenocarcinoma
Molecular Cancer
author_facet Yan Xu
Yuan Li
Jiankang Jin
Guangchun Han
Chengcao Sun
Melissa Pool Pizzi
Longfei Huo
Ailing Scott
Ying Wang
Lang Ma
Jeffrey H. Lee
Manoop S. Bhutani
Brian Weston
Christopher Vellano
Liuqing Yang
Chunru Lin
Youngsoo Kim
A. Robert MacLeod
Linghua Wang
Zhenning Wang
Shumei Song
Jaffer A. Ajani
author_sort Yan Xu
title Correction to: LncRNA PVT1 up-regulation is a poor prognosticator and serves as a therapeutic target in esophageal adenocarcinoma
title_short Correction to: LncRNA PVT1 up-regulation is a poor prognosticator and serves as a therapeutic target in esophageal adenocarcinoma
title_full Correction to: LncRNA PVT1 up-regulation is a poor prognosticator and serves as a therapeutic target in esophageal adenocarcinoma
title_fullStr Correction to: LncRNA PVT1 up-regulation is a poor prognosticator and serves as a therapeutic target in esophageal adenocarcinoma
title_full_unstemmed Correction to: LncRNA PVT1 up-regulation is a poor prognosticator and serves as a therapeutic target in esophageal adenocarcinoma
title_sort correction to: lncrna pvt1 up-regulation is a poor prognosticator and serves as a therapeutic target in esophageal adenocarcinoma
publisher BMC
series Molecular Cancer
issn 1476-4598
publishDate 2021-03-01
description An amendment to this paper has been published and can be accessed via the original article.
url https://doi.org/10.1186/s12943-021-01351-5
work_keys_str_mv AT yanxu correctiontolncrnapvt1upregulationisapoorprognosticatorandservesasatherapeutictargetinesophagealadenocarcinoma
AT yuanli correctiontolncrnapvt1upregulationisapoorprognosticatorandservesasatherapeutictargetinesophagealadenocarcinoma
AT jiankangjin correctiontolncrnapvt1upregulationisapoorprognosticatorandservesasatherapeutictargetinesophagealadenocarcinoma
AT guangchunhan correctiontolncrnapvt1upregulationisapoorprognosticatorandservesasatherapeutictargetinesophagealadenocarcinoma
AT chengcaosun correctiontolncrnapvt1upregulationisapoorprognosticatorandservesasatherapeutictargetinesophagealadenocarcinoma
AT melissapoolpizzi correctiontolncrnapvt1upregulationisapoorprognosticatorandservesasatherapeutictargetinesophagealadenocarcinoma
AT longfeihuo correctiontolncrnapvt1upregulationisapoorprognosticatorandservesasatherapeutictargetinesophagealadenocarcinoma
AT ailingscott correctiontolncrnapvt1upregulationisapoorprognosticatorandservesasatherapeutictargetinesophagealadenocarcinoma
AT yingwang correctiontolncrnapvt1upregulationisapoorprognosticatorandservesasatherapeutictargetinesophagealadenocarcinoma
AT langma correctiontolncrnapvt1upregulationisapoorprognosticatorandservesasatherapeutictargetinesophagealadenocarcinoma
AT jeffreyhlee correctiontolncrnapvt1upregulationisapoorprognosticatorandservesasatherapeutictargetinesophagealadenocarcinoma
AT manoopsbhutani correctiontolncrnapvt1upregulationisapoorprognosticatorandservesasatherapeutictargetinesophagealadenocarcinoma
AT brianweston correctiontolncrnapvt1upregulationisapoorprognosticatorandservesasatherapeutictargetinesophagealadenocarcinoma
AT christophervellano correctiontolncrnapvt1upregulationisapoorprognosticatorandservesasatherapeutictargetinesophagealadenocarcinoma
AT liuqingyang correctiontolncrnapvt1upregulationisapoorprognosticatorandservesasatherapeutictargetinesophagealadenocarcinoma
AT chunrulin correctiontolncrnapvt1upregulationisapoorprognosticatorandservesasatherapeutictargetinesophagealadenocarcinoma
AT youngsookim correctiontolncrnapvt1upregulationisapoorprognosticatorandservesasatherapeutictargetinesophagealadenocarcinoma
AT arobertmacleod correctiontolncrnapvt1upregulationisapoorprognosticatorandservesasatherapeutictargetinesophagealadenocarcinoma
AT linghuawang correctiontolncrnapvt1upregulationisapoorprognosticatorandservesasatherapeutictargetinesophagealadenocarcinoma
AT zhenningwang correctiontolncrnapvt1upregulationisapoorprognosticatorandservesasatherapeutictargetinesophagealadenocarcinoma
AT shumeisong correctiontolncrnapvt1upregulationisapoorprognosticatorandservesasatherapeutictargetinesophagealadenocarcinoma
AT jafferaajani correctiontolncrnapvt1upregulationisapoorprognosticatorandservesasatherapeutictargetinesophagealadenocarcinoma
_version_ 1724200157992452096